Compare AJANTA PHARMA with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA JUBILANT LIFE SCIENCES AJANTA PHARMA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 27.7 15.8 175.9% View Chart
P/BV x 6.8 2.9 232.7% View Chart
Dividend Yield % 0.5 0.5 101.7%  

Financials

 AJANTA PHARMA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
JUBILANT LIFE SCIENCES
Mar-19
AJANTA PHARMA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,422898 158.3%   
Low Rs898618 145.4%   
Sales per share (Unadj.) Rs233.5572.0 40.8%  
Earnings per share (Unadj.) Rs44.036.2 121.4%  
Cash flow per share (Unadj.) Rs52.259.5 87.6%  
Dividends per share (Unadj.) Rs9.004.50 200.0%  
Dividend yield (eoy) %0.80.6 130.7%  
Book value per share (Unadj.) Rs255.1301.9 84.5%  
Shares outstanding (eoy) m88.02159.28 55.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.01.3 374.9%   
Avg P/E ratio x26.420.9 126.1%  
P/CF ratio (eoy) x22.212.7 174.6%  
Price / Book Value ratio x4.52.5 181.2%  
Dividend payout %20.512.4 164.8%   
Avg Mkt Cap Rs m102,081120,694 84.6%   
No. of employees `0006.82.4 284.5%   
Total wages/salary Rs m4,30719,260 22.4%   
Avg. sales/employee Rs Th3,022.638,120.6 7.9%   
Avg. wages/employee Rs Th633.48,058.4 7.9%   
Avg. net profit/employee Rs Th569.12,414.3 23.6%   
INCOME DATA
Net Sales Rs m20,55491,108 22.6%  
Other income Rs m211357 59.0%   
Total revenues Rs m20,76591,466 22.7%   
Gross profit Rs m5,66417,390 32.6%  
Depreciation Rs m7213,709 19.4%   
Interest Rs m122,198 0.5%   
Profit before tax Rs m5,14311,840 43.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m1,2733,268 39.0%   
Profit after tax Rs m3,8705,770 67.1%  
Gross profit margin %27.619.1 144.4%  
Effective tax rate %24.827.6 89.7%   
Net profit margin %18.86.3 297.3%  
BALANCE SHEET DATA
Current assets Rs m11,81245,848 25.8%   
Current liabilities Rs m3,77620,897 18.1%   
Net working cap to sales %39.127.4 142.8%  
Current ratio x3.12.2 142.6%  
Inventory Days Days7757 136.3%  
Debtors Days Days8251 160.2%  
Net fixed assets Rs m14,39865,498 22.0%   
Share capital Rs m175159 110.1%   
"Free" reserves Rs m22,27747,930 46.5%   
Net worth Rs m22,45248,089 46.7%   
Long term debt Rs m742,429 0.0%   
Total assets Rs m26,962114,685 23.5%  
Interest coverage x444.36.4 6,957.3%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.80.8 96.0%   
Return on assets %14.46.9 207.2%  
Return on equity %17.212.0 143.6%  
Return on capital %23.012.4 184.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,68212,422 86.0%   
Fx outflow Rs m2,10217,227 12.2%   
Net fx Rs m8,580-4,805 -178.6%   
CASH FLOW
From Operations Rs m3,74811,215 33.4%  
From Investments Rs m-2,228-10,118 22.0%  
From Financial Activity Rs m-1,4756,574 -22.4%  
Net Cashflow Rs m457,612 0.6%  

Share Holding

Indian Promoters % 73.8 45.6 161.8%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 1.6 8.7 17.8%  
FIIs % 7.6 21.2 35.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 21.1 80.6%  
Shareholders   20,968 23,815 88.0%  
Pledged promoter(s) holding % 4.4 15.9 27.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  SUN PHARMA  IPCA LABS  

Compare AJANTA PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

JUBILANT LIFE SCIENCES Share Price Down by 5%; BSE 500 Index Down 1.0% (Market Updates)

Jan 25, 2021 | Updated on Jan 25, 2021

JUBILANT LIFE SCIENCES share price is trading down by 5% and its current market price is Rs 956. The BSE 500 is down by 1.0%. The top gainers in the BSE 500 Index are GATEWAY DISTRIPARKS (up 10.9%) and NCC (up 6.4%). The top losers are JUBILANT LIFE SCIENCES (down 5.5%) and INFO EDGE (down 6.9%).

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 25, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS